It is increasing in incidence as a more common cancer in men, and according to recent data collated from the medical examination centers of major hospitals in Zhejiang Province, prostate cancer has ranked fifth in the incidence of tumors, and the disease of prostate cancer is more of a concern to the world. Argon helium freezing treatment for prostate cancer, urological male specialists, the secretary of the provincial Xinhua Hospital, Professor Lv Bodong led his team to take the lead in the province to successfully promote this technology, which has likewise attracted the attention of the urology discipline community and patients. The majority of the prostate cancer cases found are advanced cases. 65-year-old Mr. Zhang, a retired cadre, went to a major hospital in Hangzhou a year ago because of frequent urination, and the young doctor who saw him told him after a little examination: prostatitis, like hemorrhoids, is common in many old men, so don’t worry. The actual fact is that you can find a lot of people who are not able to get a good deal on this. The actual fact is that you can find a lot of people who are not able to get a good deal on a lot of things. The doctor was very alert and immediately asked Zhang Shiqian, director of urology, to consult. Soon, Mr. Zhang was diagnosed: prostate cancer, mid to late stage. The actual fact that there are no symptoms in the early stages of prostate cancer does not easily attract attention, and it is difficult to be detected if you do not visit a urology specialist. In developed countries, screening about prostate cancer has been one of the mandatory health checkups for middle-aged and elderly men, which we can’t do yet in China. If men over the age of 50 and men over the age of 40 who have a family history of prostate cancer are screened twice a year, most patients can be detected early. The most recent statistics show that 36.8% of prostate cancer patients in our country are in the middle stage, while only 16.5% are in the early stage and the rest are in the late stage. The early detection of prostate cancer relies on what Early detection of tumor is crucial to the treatment of tumor. The early detection of prostate cancer mainly relies on rectal diagnosis, prostate specific antigen (PSA), transrectal ultrasonography and transrectal prostate puncture biopsy. Rectal examination is the most basic and initial test. There are also tumor marker PSA (prostate-specific antigen) tests, transrectal ultrasound, and MRI to help in the early detection of prostate cancer. Of course, transrectal prostate puncture biopsy is the only way to confirm the diagnosis of prostate cancer. For those men over the age of 50 with a life expectancy of at least 10 years and men over the age of 40 with a significant family history of prostate cancer, annual rectal examinations and PSA measurements should be performed. If one of the rectal examinations and PSA measurements is abnormal, transrectal prostate ultrasound testing may be the next step, but the definitive method of diagnosis is transrectal prostate biopsy. Argon helium cryotherapy gives more options for prostate cancer treatment “Prostate cancer has a high incidence and a higher cure rate compared to other cancers, with more than 80 percent of prostate cancer surviving more than 10 years with early treatment.” Prof. Bo Dong Lu introduced. The choice of treatment for prostate cancer is based on the clinical stage of the tumor and comprehensive assessment. At present, the main treatment methods for prostate cancer are: radical prostate surgery, iodine 125 particle implantation, endocrine therapy, radiotherapy, cryotherapy, radiofrequency ablation, etc. The argon helium cryotherapy technique for prostate cancer has shown in the nearly ten-year follow-up results of thousands of patients that the patient’s five-, eight-, and ten-year prostate antigen persistence negative rates, and the patient’s survival rates are the same as the surgical results of radical surgery; in other words, the results obtained by these two techniques are the same. As a result, the American Urological Association has made the point that traditional surgery and minimally invasive coexist and that both techniques can be the treatment of choice for patients. Ar-He cryotherapy was first used only for patients with recurrence after surgery, failure of endocrine therapy, and failure of radiotherapy, and was developed as a remedial treatment technique in the process of exploration. After more than ten years of clinical practice, argon helium cryotherapy and radical surgical resection are two techniques that can provide patients with a choice, also as one of the preferred treatment methods. Minimally invasive, wide range of applications, and repeated use of recurrent tumors constitute the advantages of argon helium cryotherapy. The Department of Urology and Male Medicine of Provincial Xinhua Hospital took the lead in promoting this technology in the province. The Department of Urology of Zhejiang Xinhua Hospital took the lead in successfully carrying out this technology. “In fact, argon-helium freezing technology was first used in aerospace technology, and later applied by the medical community.” Prof. Lv Bodong introduced, “During treatment, a gas called argon helium is positioned through ultrasound, and a gas called argon helium is deepened through the probe to accurately reach the tumor site and achieve the purpose of treatment by freezing necrotic tumor tissue.” This technology has been used in Europe and America for many years. At present, there are hospitals in China such as Tianjin and Shanghai using this technology, and our province has just started. The key is that we need to improve on the treatment concept, and this technology will be gradually accepted by patients.